News & Insights
Our firm is proud to represent a diverse range of clients in a variety of commercial fields, one of which is Spirit Energy Limited (SEL) SEL started life as a new entity into which Centria plc’s… read more…
In this article, written for The Pharma Letter’s Expert View section, Mathys & Squire associate Amy Nick examines the latest developments in artificial intelligence and machine learning in the… read more…
It is important to note that as the UK leaves the European Union, EU trade marks (EUTMs) will still be valid in the other 27 member countries of the EU: Austria, Belgium, Bulgaria, Croatia, Cyprus,… read more…
We are delighted to announce that our client, medical software company Transformative AI, has raised a $17 million seed round The investment, which was led by Tera Ventures and included funding from… read more…
The UK’s exit from the EU may have an effect on all types of intellectual property (IP) where there are existing agreements or licences in place The UK is currently in a transition period until 31… read more…
During these challenging coronavirus times, digital life is at its peak – with people meeting, working and learning digitally from home Accordingly, more and more online seminars, so called… read more…
Background The efforts to create a unified patent system in Europe are now well advanced The agreement on a unified European Patent Court has been coordinated at European level and is now… read more…
In this article for Intellectual Property Magazine, Mathys & Squire associate Alexander Robinson analyses the implications of the EPO’s high-profile plant and animal ruling reversal In a… read more…
Today (15 July 2020) saw the hearing of the EPO Enlarged Board of Appeal in G 1/19 – only the second such hearing ever relating to Computer Implemented Inventions (CIIs) at the EPO While the… read more…
Mathys & Squire uses cookies
We use cookies to ensure you get the best experience on our website. More details are available via our Cookie Policy.